For the quarter ending 2025-09-30, NUVB made $13,120,000 in revenue. -$55,604,000 in net income. Net profit margin of -423.81%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 13,120,000 | 4,833,000 | 3,084,000 | 2,382,000 |
| Cost of revenue | 3,349,000 | 2,576,000 | 2,094,000 | 1,854,333.333 |
| Gross profit (deficit) | 9,771,000 | 2,257,000 | 990,000 | 527,666.667 |
| Research and development | 28,846,000 | 27,362,000 | 24,601,000 | 23,796,000 |
| Acquired in-process research and development | 0 | 0 | - | 141,690,000 |
| Selling, general and administrative | 37,359,000 | 38,484,000 | 35,393,000 | 16,550,333.333 |
| Total operating expenses | 66,205,000 | 65,846,000 | 59,994,000 | 182,036,333.333 |
| Loss from operations | -56,434,000 | -63,589,000 | -59,004,000 | -181,508,666.667 |
| Interest income | 6,033,000 | 4,780,000 | 5,321,000 | 6,778,666.667 |
| Interest expense | 6,534,000 | 421,000 | 54,000 | 73,666.667 |
| Investment advisory fees | 171,000 | 182,000 | 203,000 | 246,333.333 |
| Other expense | - | - | - | 27,250 |
| Change in fair value of warrant liability | -612,000 | -454,000 | 751,000 | 489,666.667 |
| Realized (loss) gain on marketable securities | 0 | -1,000 | 3,000 | -333.333 |
| Net gain (loss) on disposal of fixed assets | 4,000 | -34,000 | - | - |
| Other income | 698,000 | -14,000 | 1,452,000 | - |
| Total other income, net | 642,000 | 4,582,000 | 5,768,000 | 5,932,333.333 |
| Loss before income taxes | -55,792,000 | -59,007,000 | -53,236,000 | -175,576,333.333 |
| Provision for income taxes | 0 | 0 | - | - |
| Net loss | -55,792,000 | -59,007,000 | -53,236,000 | -175,576,333.333 |
| Currency translation adjustment | 313,000 | 646,000 | -465,000 | -134,250 |
| Change in unrealized gain (loss) on available-for-sale securities | 501,000 | -225,000 | -493,000 | 33,555,333.333 |
| Comprehensive loss | -55,604,000 | -59,878,000 | -53,264,000 | -141,886,750 |
| Net loss per share attributable to common stockholders, basic | -0.16 | -0.17 | -0.16 | -0.653 |
| Net loss per share attributable to common stockholders, diluted | -0.16 | -0.17 | -0.16 | -0.653 |
| Weighted average common shares outstanding, basic | 342,393 | 340,746 | 338,612 | -1,597.667 |
| Weighted average common shares outstanding, diluted | 342,393 | 340,746 | 338,612 | -1,597.667 |
Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. (NUVB)